BMP — BMP Pharma Trading AG Income Statement
0.000.00%
- €30.19m
- €30.31m
- €0.00m
- 13
- 39
- 17
- 10
Annual income statement for BMP Pharma Trading AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.001 | 0.004 | 0.002 | 0 | 0.002 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0.001 | -0.001 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.696 | 0.799 | 1.18 | 1.93 | 1.98 |
| Operating Profit | -0.694 | -0.795 | -1.18 | -1.93 | -1.98 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.298 | 3.21 | 2.22 | 4.09 | 4.19 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.17 | 2.62 | 1.57 | 2.75 | 2.88 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.17 | 2.62 | 1.57 | 2.75 | 2.88 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.17 | 2.62 | 1.57 | 2.75 | 2.88 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.032 | 0.499 | 0.299 | 0.524 | 0.548 |
| Dividends per Share |